Literature DB >> 26461041

First Demonstration of Positive Allosteric-like Modulation at the Human Wild Type Translocator Protein (TSPO).

Rajeshwar Narlawar, Eryn L Werry, Alana M Scarf, Raphy Hanani, Sook Wern Chua1, Victoria A King, Melissa L Barron, Ralph N Martins2, Lars M Ittner1, Louis M Rendina, Michael Kassiou.   

Abstract

We show that changing the number and position of nitrogen atoms in the heteroatomic core of a pyrazolopyrimidine acetamide is sufficient to induce complex binding to wild type human TSPO. Only compounds with this complex binding profile lacked intrinsic effect on glioblastoma proliferation but positively modulated the antiproliferative effects of a synthetic TSPO ligand. To the best of our knowledge this is the first demonstration of allosteric-like interaction at the wild type human TSPO.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26461041     DOI: 10.1021/acs.jmedchem.5b01288

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Reversing binding sensitivity to A147T translocator protein.

Authors:  Sophie V Vo; Samuel D Banister; Isaac Freelander; Eryn L Werry; Tristan A Reekie; Lars M Ittner; Michael Kassiou
Journal:  RSC Med Chem       Date:  2020-03-12

Review 2.  Glioblastoma: Current Status, Emerging Targets, and Recent Advances.

Authors:  Amandeep Thakur; Chetna Faujdar; Ram Sharma; Sachin Sharma; Basant Malik; Kunal Nepali; Jing Ping Liou
Journal:  J Med Chem       Date:  2022-07-05       Impact factor: 8.039

3.  Cholesterol-mediated allosteric regulation of the mitochondrial translocator protein structure.

Authors:  Garima Jaipuria; Andrei Leonov; Karin Giller; Suresh Kumar Vasa; Łukasz Jaremko; Mariusz Jaremko; Rasmus Linser; Stefan Becker; Markus Zweckstetter
Journal:  Nat Commun       Date:  2017-03-30       Impact factor: 14.919

4.  Identification of Koumine as a Translocator Protein 18 kDa Positive Allosteric Modulator for the Treatment of Inflammatory and Neuropathic Pain.

Authors:  Bojun Xiong; Guilin Jin; Ying Xu; Wenbing You; Yufei Luo; Menghan Fang; Bing Chen; Huihui Huang; Jian Yang; Xu Lin; Changxi Yu
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

5.  Determination and reduction of translocator protein (TSPO) ligand rs6971 discrimination.

Authors:  Renee Sokias; Eryn L Werry; Sook W Chua; Tristan A Reekie; Lenka Munoz; Erick C N Wong; Lars M Ittner; Michael Kassiou
Journal:  Medchemcomm       Date:  2016-11-15       Impact factor: 3.597

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.